Business

XM: A Silver Lining (XMSR)(SIRI)

XM and GM today announced that GM plans to build more than 1.8 million cars with factory installed XM receivers. On a day when Sirius is down 6% to $3.91 ...
Read Full Story »

Cramer Back to Endorsing Share Buybacks

I didn't think he would go back to this, but Cramer is actually back in favor of discussing "Share Buyback Plans" from companies as being a catalyst.You can watch his ...
Read Full Story »

Cramer Backs Away from Sirius

Cramer keys in on Sirius Satellite Radio (SIRI) in "Merger Watch for Sirius" at TheStreet.com.Jim Cramer noted that this warning out of Sirius is at a bad time, because it ...
Read Full Story »

GM Europe’s Tow Truck (GM)

GM Europe is going to make money this year, and, so they say, more money next. Its earnings for the first three quarters of 2006 are $196 million. Sales in ...
Read Full Story »

Gambling Drug Fails Trials; Somaxon Shares Lower

Somaxon Pharmaceuticals (SOMX-NASDAQ) has announced essentially failed results from the company's Phase 2/3 clinical trial evaluating 20 mg and 40 mg of oral nalmefene hydrochloride, an opiate antagonist, in patients ...
Read Full Story »

As Sirius Warns, Satellite Radio Continues Spiral Down

Stocks:  (SIRI)(XMSR)After months of indicating that it was growing rapidly and its rival XM was not, Sirius has revised its year-end subscriber projections down from 6.3 million to a range ...
Read Full Story »

Media Digest: FT, Reuters, WSJ, NY Times

Stocks:  (SNE)(DIS)(SIRI)(PFE)According to Reuters, US arms sales overseas will total about $20 billion for the year ending October 1, 2006, about even with last year's record total.Reuters writes that, based ...
Read Full Story »

Pfizer Setback Disappointing, Not Catastrophic

By Chad Brand of Peridot CapitalistI was actually planning a broader pharmaceutical post , but in light of the Pfizer (PFE) news over the weekend, I just wanted to talk ...
Read Full Story »

Onyx Pharma Tumbles As Skin Cancer Drug Fails Phase III

From BioHealth Investor Shares of Onyx Pharmaceuticals (ONXX) dropped more than 30% on Monday after the company announced at a teleconference that its phase III clinical trial evaluating its cancer ...
Read Full Story »

Analyzing Bank of America (BAC)

By Yaser Anwar, CSC of Equity Investment IdeasBAC is doing quite well lately evident by the fact that BAC has had the greatest improvement on a sequential basis of around ...
Read Full Story »

Cramer Electrifies Emerson Electric (EMR)

Tonight on CNBC's MAD MONEY, Jim Cramer also talked about what a great day today was.  He thinks the bears will have to stage a raid, but look for totem ...
Read Full Story »

Cramer Now Saying Under Armour is a Buy to the Ninth Power

Tonight on CNBC's MAD MONEY, Jim Cramer noted the war that Under Armour (UARM) is waging a war against Nike (NKE), and against the Adidas-Reebok brand.  Cramer said he is ...
Read Full Story »

Cramer Likes Cabellas and ADM

On today's STOP TRADING segment on CNBC, Jim Cramer covered a few issues.He noted Pfizer (PFE) again, saying it was another Bristol-Myers (BMY).  He said it is a $25.00 bond ...
Read Full Story »

What Elese Is Wrong With Pfizer

Pfizer (PFE) had its CEO interviwed by Mike Huckman on CNBC today.  Mike Huckman even asked him how a "guy that used to sell chicken for Boston Market that is ...
Read Full Story »

Cramer Makes More Merger Picks

Today Cramer discussed a wave of M&A after Pfizer's (PFE) blow-up today, also bank mergers predicted, and more tech deals coming.  You can watch his new video HERE on thestreet.com ...
Read Full Story »